LeadMaster integrates cutting-edge computational chemistry and bioinformatics to cover all known targets, providing one-stop support for the DMTA (Design–Make–Test–Analyze) cycle in drug discovery. With LeadMaster, research teams can complete iterative DMTA cycles on a single platform, significantly enhancing the speed and success rate of novel drug candidate discovery.